81 related articles for article (PubMed ID: 18440882)
61. Sol-gel microspheres doped with glycerol: a structural insight in light of forthcoming applications in the polyurethane foam industry.
Ciriminna R; Fidalgo A; Ilharco LM; Pagliaro M
ChemistryOpen; 2015 Apr; 4(2):78. PubMed ID: 25969799
[TBL] [Abstract][Full Text] [Related]
62. Methyllysine analogs: rewriting the code.
Bhatia M; Thompson PR
Nat Chem Biol; 2007 May; 3(5):249-50. PubMed ID: 17438548
[No Abstract] [Full Text] [Related]
63. [The relationship between absorption and refraction in microscopic preparations].
MEYER-ARENDT J; MEYER-ARENDT E
Mikroskopie; 1953; 8(7-8):235-8. PubMed ID: 13153920
[No Abstract] [Full Text] [Related]
64. Fabrication of curcumin-loaded electrospun nanofiberous polyurethanes with anti-bacterial activity.
Shababdoust A; Ehsani M; Shokrollahi P; Zandi M
Prog Biomater; 2018 Mar; 7(1):23-33. PubMed ID: 29196898
[TBL] [Abstract][Full Text] [Related]
65. A novel bioactive osteogenesis scaffold delivers ascorbic acid, β-glycerophosphate, and dexamethasone in vivo to promote bone regeneration.
Wang C; Cao X; Zhang Y
Oncotarget; 2017 May; 8(19):31612-31625. PubMed ID: 28404942
[TBL] [Abstract][Full Text] [Related]
66. Biodegradable hydrophilic polyurethane PEGU25 loading antimicrobial peptide Bmap-28: a sustained-release membrane able to inhibit bacterial biofilm formation in vitro.
Wang J; Liu Q; Tian Y; Jian Z; Li H; Wang K
Sci Rep; 2015 Mar; 5():8634. PubMed ID: 25727362
[TBL] [Abstract][Full Text] [Related]
67. Injectable foams for regenerative medicine.
Prieto EM; Page JM; Harmata AJ; Guelcher SA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):136-54. PubMed ID: 24127230
[TBL] [Abstract][Full Text] [Related]
68. Controlled release of triamcinolone acetonide from polyurethane implantable devices: application for inhibition of inflammatory-angiogenesis.
Pinto FC; Da Silva-Cunha Junior A; Oréfice RL; Ayres E; Andrade SP; Lima LD; Moura SA; Da Silva GR
J Mater Sci Mater Med; 2012 Jun; 23(6):1431-45. PubMed ID: 22466817
[TBL] [Abstract][Full Text] [Related]
69. LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomas.
Sivak WN; Pollack IF; Petoud S; Zamboni WC; Zhang J; Beckman EJ
Acta Biomater; 2008 Jul; 4(4):852-62. PubMed ID: 18440882
[TBL] [Abstract][Full Text] [Related]
70. Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profiles.
Sivak WN; Pollack IF; Petoud S; Zamboni WC; Zhang J; Beckman EJ
Acta Biomater; 2008 Sep; 4(5):1263-74. PubMed ID: 18440884
[TBL] [Abstract][Full Text] [Related]
71. Simultaneous drug release at different rates from biodegradable polyurethane foams.
Sivak WN; Zhang J; Petoud S; Beckman EJ
Acta Biomater; 2009 Sep; 5(7):2398-408. PubMed ID: 19398389
[TBL] [Abstract][Full Text] [Related]
72. Incorporation of ionic ligands accelerates drug release from LDI-glycerol polyurethanes.
Sivak WN; Zhang J; Petoud S; Beckman EJ
Acta Biomater; 2010 Jan; 6(1):144-53. PubMed ID: 19524075
[TBL] [Abstract][Full Text] [Related]
73. Degradative-release as a function of drug structure from LDI-glycerol polyurethanes.
Sivak WN; Zhang J; Petoud S; Beckman EJ
Biomed Mater Eng; 2010; 20(5):269-81. PubMed ID: 21084739
[TBL] [Abstract][Full Text] [Related]
74. Biodegradable and temperature-responsive polyurethanes for adriamycin delivery.
Sun X; Gao H; Wu G; Wang Y; Fan Y; Ma J
Int J Pharm; 2011 Jun; 412(1-2):52-8. PubMed ID: 21511019
[TBL] [Abstract][Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
